Bøger i Tissue engineering serien

I Fundamentals of Cell Encapsulation.- 1. Encapsulation and Immoblization Techniques.- 2. Mass Transfer in Immobilized Cell Systems.- 3. Polymer Membranes for Cell Encapsulation.- 4. Biocompatible Encapsulation Materials: Fundamentals and Application.- 5. Modulation of Membrane Permeability.- 6. Biocompatibility Issues.- II Encapsulation Systems Section 1 Microencapsulation.- 7. Calcium Alginate.- 8. Immunoprotection of Islets of Langerhans by Microencapsulation in Barium Alginate Beads.- 9. Agarose.- 10. Poly (ethylene glycol).- 11. Long-Term Survival of Poly-L-Lysine-Alginate Microencapsulated Islet Xenografts in Spontaneously Diabetic NOD Mice.- 12. Alginate/Poly-L-Ornithine Microcapsules for Pancreatic Islet Cell Immunoprotection Giuseppe.- 13. Chitosan.- 14. Polyacrylates.- Section 2 Macroencapsulation.- 15. Diffusion Chambers.- 16. Vascular Devices.- 17. Macrocapsules Based on Ultrafiltration and Diffusion.- III Applications of Encapsulated Cell Systems Section 1 Primary Cells.- 18. Artificial Pancreas.- 19. Microencapsulated Islets in Type I Diabetics: Clinical Experience.- 20. Transplantation of Microencapsulated Parathyroid Tissue: Clinical Background, Methods, and Current Status of Research.- 21. Bioartificial Livers.- 22. Renal Replacement Devices: The Development of the Bioartificial Kidney.- 23. Encapsulation of Mammalian Embryos.- 24. Encapsulated Plant Cells: Techniques and Applications.- Section 2 Genetically Engineered Cells.- 25. Implantable Microcapsules for Gene Therapy for Hemophilia.- 26. Microencapsulation: A Novel Gene Therapy for Lysosomal Storage Diseases.- 27. Growth Hormone Gene Therapy Using Encapsulated Myoblasts.- 28. Transplantation of Encapsulated Cells into the Central Nervous System.- 29. Removal of Urea in Uremia and Ammonia in Liver Failure with Emphasis on the Use of Artificial Cells for Encapsulation of Genetically Engineered Cells.- Section 3 Bioreactor Culture.- 30. Principles of Bioreactor Design for Encapsulated Cells.- 31. Culture of Anchorage-Dependent Cells.

This body of work represents the first volume of a book series covering the field of tissue engineering. Tissue engineering, which refers to a category of therapeutic or diagnostic products and processes which are based upon a combination of living cells and biomaterials, was defined as a field only a few years ago (1988). Tissue engineering is an inherently interdisciplinary field, combining bioengineering, life sciences and clinical sciences. The definition of this area of work as the field of tissue engineering brought together scientists from multiple backgrounds who already were working toward the achievement of similar goals. Why a book series exclusively devoted to tissue engineering? The field of tissue engineering is heterogeneous. The cells involved in tissue engineering can be autologous, allogeneic or xenogeneic. The biomaterials utilized can be either naturally occurring, synthetic or a combination of both. The appli- cation of the technology can be either for acute or permanent purposes. An attempt to cover the field of tissue engineering in a single volume, with the degree of detail necessary for individuals with different scientific back- grounds and disciplines, would be a difficult task to accomplish, particularly when this field is just emerging and changing rapidly. Therefore, addressing different technologies within the field of tissue engineering, in a comprehen- sive manner, is the main mission of this series of volumes. A stellar group of scientists has been brought together to form the editorial board of the series.